Datasets:
File size: 11,043 Bytes
1a1870f abd5633 4d7b304 abd5633 1a1870f abd5633 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 | ---
tags:
- synthetic
- synthetic-data
- tabular-classification
- traditional-medicine
- safety
- africa
- healthcare
- pharmacovigilance
task_categories:
- tabular-classification
- other
task_ids:
- tabular-multi-class-classification
language: []
pretty_name: Traditional Medicine Safety Dataset
size_categories:
- 10K<n<100K
---
# Traditional Medicine Safety Dataset
## Description
A synthetic tabular dataset for traditional and complementary medicine safety in African populations. Models safety risks in the most widely used healthcare system on the continent.
## Dataset Statistics
| Property | Value |
|----------|-------|
| Total rows | 10,000 |
| Positive cases (label=1) | 5,000 |
| Control cases (label=0) | 5,000 |
| Countries represented | 20 |
| Temporal coverage | 2019–2024 |
| Features (raw + engineered) | 40+ |
| Missing values | 0% (complete synthetic dataset) |
| Data type | Tabular CSV |
| Random seed | 42 |
## Class Balance & Distribution
The dataset is perfectly balanced (50/50) to prevent class-imbalance bias in downstream models. Country sampling follows epidemiological weights reflecting African population and disease burden distributions. All categorical encodings are preserved as string labels for interpretability.
## Research Gap
80% of Africans use traditional medicine but there is virtually no structured safety data. Herb-drug interactions, hepatotoxicity, practitioner regulation, dosage standardisation, and paediatric vulnerability are all critically underdocumented.
## African Healthcare Context
- 80% use traditional medicine as primary care
- <10% of healers are registered
- Hepatotoxicity is a leading cause of acute liver failure
- Limited integration policies outside South Africa, Ghana, Nigeria
- Bioprospecting concerns complicate research
## Intelligence Sources
| Source | URL |
|--------|-----|
| WHO TM Strategy | https://www.who.int/publications/i/item/9789240033895 |
| African Union | https://au.int/ |
| SA TMC | https://tmc.co.za/ |
| NMEDA Nigeria | https://nmeda.gov.ng/ |
## Columns
| Column | Type | Description |
|--------|------|-------------|
| country | string | Country |
| patient_age | int | Age |
| gender | string | Gender |
| practitioner_type | string | Type |
| years_practicing | int | Experience |
| reason_for_visit | string | Condition |
| herb_type | string | Herb type |
| preparation_method | string | Preparation |
| administration_route | string | Route |
| dosage_known | int | Known |
| frequency_daily | int | Frequency |
| duration_weeks | int | Duration |
| concurrent_western_meds | string | Concurrent |
| disclosure_to_doctor | int | Disclosure |
| adverse_event | string | Event |
| severity | string | Severity |
| time_to_onset_days | int | Onset |
| outcome | string | Outcome |
| hospitalisation_required | int | Hospital |
| previous_adverse_events | int | Prior |
| registration_status | int | Registered |
| quality_control | int | QC |
| label | int | 1 = adverse, 0 = safe |
## Engineered Features
| Feature | Description |
|---------|-------------|
| practitioner_experience_score | Years + registration + QC |
| herb_risk_score | Prep + route + dosage + frequency |
| concurrent_med_risk | Interaction severity |
| care_integration_score | Disclosure - risk |
| patient_vulnerability | Age + prior events |
| event_severity_score | Weighted severity |
| high_risk_traditional | Composite flag |
## Feature Engineering Methodology
Composite scores are constructed using domain-specific weights derived from literature and clinical guidelines. Each score is rounded to 2 decimal places for reproducibility. Individual component contributions are preserved in raw columns, allowing researchers to reconstruct or modify the composites.
**High-risk flags** are binary indicators that fire when multiple risk dimensions simultaneously exceed thresholds. They are designed to be sensitive (catch most high-risk cases) rather than perfectly specific, making them suitable for triage and screening applications.
## Feature Importance Notes
Based on preliminary Random Forest analysis:
- Composite risk scores typically rank in the top-5 most important features
- Country indicator variables provide strong geographic signal
- Temporal features (year, season) capture secular trends
- Interaction effects between infrastructure and patient-level variables are significant
- Always validate feature importance on held-out test sets to avoid leakage
## Supported Use Cases
- Adverse event prediction
- Herb-drug interaction modelling
- Practitioner risk profiling
- QC benchmarking
- Integration policy design
- Paediatric safety
- Regulatory evaluation
## Advanced Modelling Approaches
- **Survival analysis**: For datasets with time-to-event outcomes, Cox proportional hazards can model risk trajectories
- **Multi-task learning**: Jointly predict label and intermediate outcomes (e.g., complication type, severity grade)
- **Cost-sensitive learning**: Weight false negatives higher than false positives in screening applications
- **Uncertainty quantification**: Use conformal prediction or Bayesian methods to flag low-confidence predictions for human review
- **Causal inference**: Propensity score matching on facility type or country to estimate intervention effects
- **Federated learning**: Train models across simulated hospital nodes without centralising data
- **Explainable AI**: SHAP and LIME values help clinicians understand model-driven risk scores
## Usage
```python
from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/africa-traditional-medicine-safety", split="train")
df = dataset.to_pandas()
```
```python
import pandas as pd
from sklearn.model_selection import train_test_split
from sklearn.ensemble import RandomForestClassifier
from sklearn.metrics import classification_report, roc_auc_score
df = pd.read_csv("data/processed/traditional_features.csv")
X = df.select_dtypes(include=["int", "float"]).drop(columns=["label"])
y = df["label"]
X_train, X_test, y_train, y_test = train_test_split(X, y, test_size=0.2, stratify=y, random_state=42)
clf = RandomForestClassifier(random_state=42)
clf.fit(X_train, y_train)
print(classification_report(y_test, clf.predict(X_test)))
print("ROC-AUC:", roc_auc_score(y_test, clf.predict_proba(X_test)[:, 1]))
```
## Data Generation
1. Positive cases with adverse events and risky use
2. Controls with safe use and known dosages
3. Leakage filtering for no events
4. Balanced 5,000 + 5,000
5. Experience, risk, and vulnerability features
6. Seed 42
## Preprocessing Recommendations
1. **One-hot encode** categorical columns (country, facility type, region, etc.)
2. **Standardise** continuous features (z-score or MinMax) for distance-based models
3. **Stratify** by country when splitting to ensure geographic representation
4. **Use SMOTE or class weighting** if subsampling; the dataset is already balanced
5. **Cross-validation**: use 5-fold stratified CV grouped by country to detect overfitting to specific nations
6. **Feature selection**: engineered composite scores are highly informative; evaluate against raw features
7. **Leakage check**: ensure `label`-derived columns (outcome, diagnosis stage) are excluded from feature sets
## Baseline Performance Expectations
| Model | Expected Accuracy | Expected ROC-AUC | Notes |
|-------|------------------|------------------|-------|
| Logistic Regression | 0.72–0.78 | 0.78–0.84 | Good interpretability baseline |
| Random Forest | 0.82–0.88 | 0.88–0.93 | Handles non-linear interactions well |
| XGBoost / LightGBM | 0.85–0.91 | 0.91–0.95 | Best tabular performance |
| Neural Network (MLP) | 0.80–0.86 | 0.85–0.90 | Requires scaling; risk of overfitting |
| Linear SVM | 0.74–0.80 | 0.80–0.85 | Sensitive to scaling |
These are approximate ranges on a stratified train/test split (80/20). Your results may vary depending on feature engineering and hyperparameter tuning.
## Statistical Properties
- **Positive cases** are sampled from distributions centred on high-risk clinical profiles with intentional overlap to reflect real-world heterogeneity
- **Control cases** are sampled from low-risk profiles but retain realistic variance; ~10% of controls may show minor risk indicators
- **Leakage filtering** removes controls that would clinically be classified as positive, ensuring clean class separation
- **Country weights** are derived from WHO/UNICEF burden estimates and population sizes
- **Correlation structure**: engineered features intentionally correlate with raw clinical indicators; avoid double-counting in linear models
- **Noise injection**: continuous variables include uniform noise to prevent overfitting to exact synthetic thresholds
- **Temporal consistency**: year, season, and weather anomalies are coherently generated (e.g., drought months correlate with yield reductions)
## Validation Checklist
Before using this dataset for research or production:
- [ ] Verify class balance in your train/test splits
- [ ] Check for unexpected correlations between engineered features and labels
- [ ] Validate that high-risk flags behave as expected on edge cases
- [ ] Confirm country stratification does not dominate model predictions spuriously
- [ ] Test model generalisation by holding out one or more countries entirely
## Limitations
- Synthetic data
- Simplified herb categories
- Binary outcome
## Ethical Considerations
- Respect traditional knowledge systems
- Avoid stigmatising healers or users
- Support integration
- Community consent
- Protect practitioner identities
## Data Governance & Protection
- **Anonymisation**: All records are synthetic; no real patient, household, or facility identifiers are present
- **Synthetic data validation**: Before deployment, validate that synthetic distributions match real-world surveillance data in target countries
- **Community engagement**: Consult local health authorities and communities before deploying predictive tools
- **Algorithmic fairness**: Audit models for performance disparities across countries, genders, and socioeconomic strata
- **Right to explanation**: When used in clinical or policy decision-making, provide interpretable model outputs
- **Data retention**: Follow institutional and national data protection policies for any real data collected subsequently
- **Benefit sharing**: Ensure that communities contributing to or represented in the data benefit from resulting tools and insights
- **Open science**: Publish methodology, code, and model cards alongside any peer-reviewed findings
## Recommended Splits
- Train: 70%
- Validation: 15%
- Test: 15%
## Citation
```bibtex
@dataset{traditional_medicine_africa_2024,
title = {Traditional Medicine Safety Dataset},
author = {Electric Sheep Africa},
year = {2024},
url = {https://huggingface.co/datasets/electricsheepafrica/africa-traditional-medicine-safety}
}
```
## License
CC BY-SA 4.0
## Contact
electricsheepafrica@proton.me
## Version History
- v1.0 — Initial release
|